Refine by
Patient Well Being Articles & Analysis
24 news found
Medical science is witnessing remarkable advancements in neurology and oncology, with cutting-edge technologies shaping the future of patient care. Transcranial techniques are improving neurological diagnostics, while tumor tissue-based technology is revolutionizing cancer treatment, particularly in prostate cancer screening. In dermatology, new methods for treating benign ...
Summary Attending a loupe fair is an exciting and essential milestone for dental and hygiene students. Loupes are a critical tool in modern dentistry, enhancing precision and ergonomics during procedures. Choosing the right pair of loupe and LED headlight can significantly impact your comfort and performance. Here’s a guide to help dental and hygiene students prepare for a loupe fair, ...
At best, most of us tolerate needles. Whether a vaccine, an IV drip, or a blood draw, we can talk ourselves through it with the knowledge that it is for the greater good and will only cause temporary discomfort. On the other side of the spectrum, there are people with such an intense fear of needles that they are considered to have a phobia, trypanophobia to be precise. Many articles have been ...
These innovative systems have revolutionized the way medications are administered, enhancing patient comfort and ensuring optimal therapeutic efficacy. Transdermal drug delivery systems are very popular due to their benefits, such as improving bioavailability and reducing side effects. ...
We are delighted to welcome Saint Catherine’s Hospice Scarborough to the growing community of amazing hospice charities we work with across the UK. We are proud to provide Saint Catherine’s with our affordable and adaptable software solutions that support the outstanding care they provide to people with life-limiting ...
These conditions pose significant challenges to patients' health and well-being. To delve into these diseases, rodents are commonly employed as research subjects in cognitive-behavioral testing. ...
Through this collaboration, xCures will help eligible pancreatic cancer patients access a Phase III clinical study entitled, Targeted Intra-arterial Gemcitabine vs. ...
ByxCures
On behalf of the Company, I wish them well in their future endeavors.” For more information on our website about Ed Mathers, Nanna Lüneborg and our complete Board of Directors, click here. ...
Increasing the number and accessibility of testing methods can provide new options and opportunities to testing centers, as well as alleviate certain costs at testing sites for equipment related to administering and processing tests. ...
Prostate cancer is the most common type of cancer in men. Every year this diagnosis is made about 900 thousand times, in developed countries the disease affects up to 14% of the entire male population with oncology due to longer life expectancy. We spoke with adult prostate cancer survivors. ...
Marking “World Sepsis Day”, The Centre for Drug Research and Development (CDRD) announces the spin-off of a new company, Sepset Biosciences Inc. The company is developing a novel rapid diagnostic test that will enable healthcare professionals to provide earlier and more targeted treatment of sepsis – a global healthcare problem that is more common than heart attack and claims ...
The evaluation of the RedOx balance might improve the network of clinical parameters characterizing the patient’s well-being, as part of an growing widespread customization of medicine and with the aim of making increasingly targeted and patient-tailored choices. ...
Adilson Magri, Chief Executive Officer of Grupo Suprimed´s said, "The success and sustainability of a business in the medical field depends on improved quality of life for patients and functionality for healthcare professionals. With this goal in mind, our distribution portfolio brings innovative, high-tech and efficient solutions to the healthcare market." ...
The trial met its primary endpoint, demonstrating that Lomecel-B was well tolerated in this patient population. In addition, the data provided indications supporting further exploration of Lomecel-B, particularly the therapeutic potential to slow cognitive decline and improve quality of life in patients with AD. ...
The ArthroFree system is designed to deliver improved operating room productivity, patient safety, and economic value through cost-savings, energy efficiency, and reduced setup/breakdown times. ...
View the full release here: https://www.businesswire.com/news/home/20211223005112/en/ “The combination with Ortho will help solidify Quidel as a leader in the diagnostics industry, bringing together innovative, complementary products, solutions, and services that enhance the health and well-being of patients across the globe,” said ...
The operation comes under secured global financing of close to €100 million in equity, quasi-equity and debt financing. The investment is being made through the €25 billion European Guarantee Fund to support the recovery of European businesses following the COVID-19 pandemic. ...
Much like finding a match for an organ transplant, the PARIS® Test found a drug match for this patient. Within a month of treatment with the PARIS®-guided therapy, the cancer marker CA125 decreased by half, and after 6 months the patient was well and traveling for vacation. ...
Their main objective? To improve patients’ quality of life by developing a technological solution offering minimum risk and maximum support for the patient. ...
The primary goal of the study is to evaluate healing time, with the secondary objectives of assessing patients’ satisfaction, well-being, self-esteem, body image, psychological well-being, nipple dimensions, and sensitivity. ...